PM4Onco - Personalized Medicine for Oncology
Cancer is one of the leading causes of death worldwide. Genetically, they are very heterogeneous according the somatic mutations they acquired over years and decades during their evolution within the host.
The PM4Onco consortium aims to strengthen Personalized Medicine in cancer care by building an alliance between the German Medical Informatics Initiative (MII), the top oncological centers and consortia, clinical cancer registries, junior researchers, patients and citizens.
By integrating cutting-edge technology, comprehensive data analysis and interdisciplinary collaboration, advances are being made to overcome the challenges of cancer treatment at the individual level.
As a local project partner we are closely collaborating with the molecular tumor board of the UCCSH and the Medical Data Integration Center (MeDIC).
More information is available on the PM4Onco project website.